AJP - Heart and Circulatory Physiology, Vol 270, Issue 4 1172-H1177, Copyright © 1996 by American Physiological Society

ARTICLES

Analysis of responses to angiotensin I-(3-10) in the hindlimb vascular bed of the cat

E. A. Garrison and P. J. Kadowitz
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

Responses to angiotensin I-(3-10), the precursor for angiotensin IV, were investigated in the anesthetized cat. Intravenous injections of the precursor caused dose-related increases in systemic arterial pressure that were similar to responses elicited by angiotensin i.v. and that were inhibited by captopril. in the hindlimb vascular bed of the cat under constant-flow conditions, injections of the substrate into the perfusion circuit in doses of 3-100 micrograms caused dose-related increases in hindlimb perfusion pressure that were rapid in onset and were not altered by the presence of a time-delay coil in the perfusion circuit. Dose-response curves for the precursor and angiotensin i.v. were parallel, and the precursor was approximately twofold less potent than angiotensin i.v. in its ability to increase hindlimb perfusion pressure. Responses to the precursor were inhibited by captopril in a dose that attenuated hindlimb vasoconstrictor responses to angiotensin I. Increases in hindlimb perfusion pressure in response to angiotensin I-(3-10) were inhibited by DuP-532 in a dose that attenuated the response to angiotensin i.v. PD-123,319, an AT2 receptor antagonist, had no significant effect on responses to angiotensin I-(3-10). The present results suggest that angiotensin I-(3-10) is rapidly and efficiently converted by an angiotensin converting enzyme-dependent pathway into an active peptide, which induces vasoconstriction by activating AT1 receptors in the peripheral vascular bed of the cat.

This article has been cited by other articles:

				V. Esteban, M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, O. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, and M. Ruiz-Ortega Angiotensin IV Activates the Nuclear Transcription Factor-{kappa}B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells Circ. Res., May 13, 2005; 96(9): 965 - 973. [Abstract] [Full Text] [PDF]

				J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988. [Abstract] [Full Text] [PDF]

				R. K. HANDA Characterization and Signaling of the AT4 Receptor in Human Proximal Tubule Epithelial (HK-2) Cells J. Am. Soc. Nephrol., March 1, 2001; 12(3): 440 - 449. [Abstract] [Full Text]

				L. Loufrani, D. Henrion, D. Chansel, R. Ardaillou, and B. I. Levy Functional Evidence for an Angiotensin IV Receptor in Rat Resistance Arteries J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 583 - 588. [Abstract] [Full Text]

				R. K. Handa, L. T. Krebs, J. W. Harding, and S. E. Handa Angiotensin IV AT4-receptor system in the rat kidney Am J Physiol Renal Physiol, February 1, 1998; 274(2): F290 - F299. [Abstract] [Full Text] [PDF]

				H. C. Champion, M. A. Czapla, and P. J. Kadowitz Responses to angiotensin peptides are mediated by AT1 receptors in the rat Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E115 - E123. [Abstract] [Full Text] [PDF]

				H. C. Champion and P. J. Kadowitz Analysis of the Effects of Candesartan in the Mesenteric Vascular Bed of the Cat Hypertension, November 1, 1997; 30(5): 1260 - 1266. [Abstract] [Full Text]